Evaluation of measles-rubella vaccination for mothers in early puerperal phase

Vaccine. 2016 Feb 24;34(9):1208-14. doi: 10.1016/j.vaccine.2016.01.015. Epub 2016 Jan 19.

Abstract

Background: The postpartum period is an ideal opportunity to vaccinate mothers with inadequate immunity to vaccine-preventable diseases including measles and rubella.

Methods: A prospective study of measles-rubella (MR) vaccination in the early puerperal phase was conducted in 171 mothers, who had insufficient antibody titers when screened for immunity to measles (≤ 1:4 on the neutralization test [NT]) or rubella (≤ 1:16 on the hemagglutination inhibition [HI] test) during pregnancy. To evaluate the efficacy of MR vaccination in the postpartum period, we determined their post-vaccination antibody titers and immune responses to vaccination, and investigated the association between these and their prolactin (PRL) levels and Th1/Th2 ratios at the time of vaccination. We also examined the passage of viral RNA and antigen into breast milk.

Results: Of the 169 participants who completed the study schedule, 117 and 101 had low antibody titers against measles and rubella, respectively. In the measles-seronegative group, the antibody-positive rate was 87% on the NT assay, and the NT geometric mean antibody titer was 11.4 (95% confidence interval [CI], 10.0-13.0). In the rubella-seronegative group, the antibody-positive rate was 88% on the HI test assay, and the HI geometric mean antibody titer was 64.0 (95% CI, 53.9-76.0). There was no association between the post-vaccination antibody titers and the PRL levels or Th1/Th2 ratios at the time of vaccination. In the rubella-seronegative group, subjects with higher Th1/Th2 ratios showed higher rates of responsiveness than those with lower ratios (P=0.045). Although measles virus RNA was isolated from the breast milk of two vaccinated mothers, breastfeeding was not associated with clinical disease in any infants.

Conclusion: MR vaccination in the early puerperal phase is considered an effective way to prevent the diseases, regardless of the mother's immunological status and hormonal milieu.

Keywords: Breastfeeding; MR vaccine; Measles; Postpartum period; Pregnancy; Rubella.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antibodies, Viral / blood*
  • Antigens, Viral / isolation & purification
  • Female
  • Hemagglutination Inhibition Tests
  • Humans
  • Immunization Schedule
  • Measles / prevention & control*
  • Measles Vaccine / administration & dosage*
  • Measles Vaccine / therapeutic use
  • Milk, Human / virology
  • Neutralization Tests
  • Postpartum Period*
  • Pregnancy
  • Prolactin / blood
  • Prospective Studies
  • RNA, Viral / isolation & purification
  • Rubella / prevention & control*
  • Rubella Vaccine / administration & dosage*
  • Rubella Vaccine / therapeutic use
  • Th1-Th2 Balance
  • Vaccines, Attenuated / administration & dosage
  • Vaccines, Attenuated / therapeutic use

Substances

  • Antibodies, Viral
  • Antigens, Viral
  • Measles Vaccine
  • RNA, Viral
  • Rubella Vaccine
  • Vaccines, Attenuated
  • Prolactin